Project Grant R21NS135258
Award Date
9/15/23
Completion Date
8/31/25
Dollars Obligated
$545K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78227, USA
Similar Awards
This $769,115 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will advance scientific understanding of how neurotropic viruses, including flaviviruses and alphaviruses, can directly enter the central nervous system (CNS) and cause severe illness. The principal investigators will explore the role of newly described meningeal structures, called arachnoid cuff exit (ACE) points, in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop a mouse model for studying the pathogenesis of Lyme neuroborreliosis. The $187,734 award will fund research to identify mouse strains that are permissive to entry of Borrelia burgdorferi spirochetes into the central and peripheral nervous systems, develop inflammatory lesions, and exhibit neurological...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $794,967 Project Grant (CFDA 93.853) to the Augusta University Research Institute, Inc. to develop a murine glioblastoma model that is permissive to oncolytic herpes simplex virus (oHSV) therapy. The overall goal is to create an immune-competent mouse model that can reproducibly simulate human grade IV brain tumors and be utilized to evaluate the safety and efficacy of oHSV-based biotherapies for this highly aggressive...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $790,000 Project Grant (R01AI183793) to the Regents of the University of Minnesota to conduct research on innate immune mechanisms controlling the neurological impacts of West Nile virus (WNV) infection. The goal of the 5-year award, with a project period from Sep 3, 2024 to Aug 31, 2029, is to gain a deeper molecular understanding of WNV...
This $470,977 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to improve understanding of the neurological mechanisms underlying cerebral malaria in children. The research aims to establish altered cerebral blood flow and metabolism as contributors to neurological injury in cerebral malaria, as well as identify associated...
This $2,940,870 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to identify and characterize the cells that harbor persistent, non-productively replicating Chikungunya virus (CHIKV) RNA in chronic CHIKV arthritis. The research aims to test the hypothesis that this persistent viral RNA acts as a pathogen-associated molecular pattern (PAMP) to drive...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $431,750 R21 project grant (CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders) to Rutgers, The State University of New Jersey to study the role of the RIPK3 protein in protecting neurons from excitotoxicity during Zika virus infection. The two-year project will use a combination of pharmacogenetics, imaging, molecular biology, and electrophysiology to investigate how RIPK3...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $512,056 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the Rector & Visitors of the University of Virginia. This 5-year grant, effective August 1, 2024, will support research to explore how the cell death pathway mediated by the enzyme caspase-8 helps control Toxoplasma gondii infection in the central nervous system. The research aims to...
This federal Project Grant award, issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to investigate the role of the reactive glycolytic byproduct methylglyoxal (MG) in triggering early-onset neurological disorders in people living with HIV infection. The total award amount is $230,250, with a performance period from August 15, 2024 to June 30, 2026. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $299,969 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to L2 Diagnostics LLC, a for-profit limited liability company based in Woodbridge, Connecticut. The funding supports research to evaluate a mosquito salivary protein, AGBR1, as a vaccine candidate against Chikungunya virus, an arthropod-borne virus primarily transmitted by Aedes mosquitoes. L2 Diagnostics will conduct...